Information about Basf Pharma Belgium
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Basf Pharma Belgium (SA)

BE 0845.445.466

Scheldelaan 600, 2040 Antwerpen
Company information
Status
Active
Enterprise number
BE0845.445.466
VAT liability
No
Established
23-04-2012
Last balance sheet year
2023
Company size
Medium-sized 0 FTE
Principal activity
Manufacture of other organic basic chemicals
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Basf Pharma Belgium
{{translate("download")}}

Publications in the Belgian Official Journal from Basf Pharma Belgium

Date Publication
24-02-2025 Resignations - Appointments (NL)
12-06-2024 Resignations - Appointments (NL)
11-05-2023 Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
20-05-2022 Resignations - Appointments (NL)
03-08-2021 Resignations - Appointments (NL)

Frequently asked questions

What is the enterprise number of Basf Pharma Belgium?
The enterprise number of Basf Pharma Belgium is BE0845445466.
When was Basf Pharma Belgium founded?
Basf Pharma Belgium was founded on 23-04-2012.
What is the address of Basf Pharma Belgium?
The current registered office of Basf Pharma Belgium is located at Scheldelaan 600, 2040 Antwerpen.
When was the last time Basf Pharma Belgium filed their annual financial statements?
The most recent financial statements of Basf Pharma Belgium were filed on 17-05-2024. You can view them here.
How many employees does Basf Pharma Belgium have?
There are currently no employees working at Basf Pharma Belgium or no workforce information is available.
What is the annual turnover of Basf Pharma Belgium?
At the time of its most recent financial statements, Basf Pharma Belgium did not publish any turnover figures. Basf Pharma Belgium reported a gross margin of -€52,613.41.

Sources